Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$21.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 25 most recent Form 4 transactions.
| Jul 9 | BBIO | BridgeBio Pharma, Inc. | MEXER◷◆ | 112,422 | — | — | — | Open the original filing on SEC.gov |
| Jul 9 | BBIO | BridgeBio Pharma, Inc. | MEXER◷◆ | 19,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 9 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 112,422 | $90.00 | $10.1M | -93.1% | Open the original filing on SEC.gov |
| Jul 9 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 36,167 | $84.00 | $3M | -23.0% | Open the original filing on SEC.gov |
| Jul 9 | BBIO | BridgeBio Pharma, Inc. | MEXER◷ | 17,167 | $16.75 | $287.5K | +12.3% | Open the original filing on SEC.gov |
| Jul 9 | BBIO | BridgeBio Pharma, Inc. | MEXER◷ | 112,422 | $29.00 | $3.3M | +410.6% | Open the original filing on SEC.gov |
| Jul 9 | BBIO | BridgeBio Pharma, Inc. | MEXER◷ | 19,000 | $8.45 | $160.6K | +226.7% | Open the original filing on SEC.gov |
| Jun 24 | BBIO | BridgeBio Pharma, Inc. | MEXER◷◆ | 17,167 | — | — | — | Open the original filing on SEC.gov |
| Jun 24 | BBIO | BridgeBio Pharma, Inc. | MEXER◷◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 24 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 37,167 | $70.00 | $2.6M | -81.6% | Open the original filing on SEC.gov |
| Jun 24 | BBIO | BridgeBio Pharma, Inc. | MEXER◷ | 17,167 | $16.75 | $287.5K | +60.5% | Open the original filing on SEC.gov |
| Jun 24 | BBIO | BridgeBio Pharma, Inc. | MEXER◷ | 20,000 | $8.45 | $169K | +238.6% | Open the original filing on SEC.gov |
| Jun 23 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 2,196 | $68.57 | $150.6K | -20.8% | Open the original filing on SEC.gov |
| Jun 22 | BBIO | BridgeBio Pharma, Inc. | AGRANT◷◆ | 5,277 | — | — | — | Open the original filing on SEC.gov |
| Jun 22 | BBIO | BridgeBio Pharma, Inc. | AGRANT◷ | 3,990 | — | — | +60.6% | Open the original filing on SEC.gov |
| Jun 15 | BBIO | BridgeBio Pharma, Inc. | MEXER◷◆ | 17,167 | — | — | — | Open the original filing on SEC.gov |
| Jun 15 | BBIO | BridgeBio Pharma, Inc. | MEXER◷◆ | 65,921 | — | — | — | Open the original filing on SEC.gov |
| Jun 15 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 1,503 | $67.14 | $100.9K | -18.6% | Open the original filing on SEC.gov |
| Jun 15 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 88,737 | $66.62 | $5.9M | -91.6% | Open the original filing on SEC.gov |
| Jun 15 | BBIO | BridgeBio Pharma, Inc. | MEXER◷ | 17,167 | $16.75 | $287.5K | +21.6% | Open the original filing on SEC.gov |
| Jun 15 | BBIO | BridgeBio Pharma, Inc. | MEXER◷ | 65,921 | $8.45 | $557K | +479.7% | Open the original filing on SEC.gov |
| Jun 3 | DNLI | Denali Therapeutics Inc. | AGRANT◆ | 19,226 | — | — | — | Open the original filing on SEC.gov |
| Jun 3 | DNLI | Denali Therapeutics Inc. | AGRANT | 6,408 | — | — | +24.6% | Open the original filing on SEC.gov |